Skip to content
DefDex

Federal award

FAST-TRACK DRUGS & BIOLOGICS, L.L.C.

N6264518P2060

Contract

Obligated and Ceiling

Obligated (net)
$156,829.95
Ceiling (potential value, not spending)
$156,829.95
Current value
$156,829.95
Gross positive obligations
$156,829.95

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
FAST-TRACK DRUGS & BIOLOGICS, L.L.C. · VFJJWFYK8PD3
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
FAST-TRACK DRUGS & BIOLOGICS, L.L.C. · VFJJWFYK8PD3
Awarding agency
Department of War · sub-agency 1700 · office N62645
Funding agency
Department of War · sub-agency 1700
Product or service (PSC)
AN42 · HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
Industry (NAICS)
541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PIID
N6264518P2060
Award type code
B
Actions
3 · Jul 26, 2018 to Jul 29, 2019
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History3

Award actions
DateFYModAction typeObligationCompany in company totals
Jul 29, 2019FY2019P00002B$31,365.99
—
May 20, 2019FY2019P00001M$0.00
—
Jul 26, 2018FY20180—$125,463.96
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.